NEW YORK (GenomeWeb News) – Qiagen today said that it will transfer distribution rights for the Olerup line of molecular transplantation testing products to LinkMed subsidiary Olerup International on July 1.

The testing products included in the agreement are used for DNA HLA typing. The transfer of assets will include all Olerup SSP HLA sales infrastructure and offices in Austria.